SE425391B - Forfarande for framstellning av 3-(3-karboxi-4-hydroxifenyl)-4,5-dihydro-2-fenylbens /e/ indol med verdefulla terapeutiska egenskaper - Google Patents

Forfarande for framstellning av 3-(3-karboxi-4-hydroxifenyl)-4,5-dihydro-2-fenylbens /e/ indol med verdefulla terapeutiska egenskaper

Info

Publication number
SE425391B
SE425391B SE7706526A SE7706526A SE425391B SE 425391 B SE425391 B SE 425391B SE 7706526 A SE7706526 A SE 7706526A SE 7706526 A SE7706526 A SE 7706526A SE 425391 B SE425391 B SE 425391B
Authority
SE
Sweden
Prior art keywords
phenylbenes
hydroxifenyl
indol
worldwide
dihydro
Prior art date
Application number
SE7706526A
Other languages
English (en)
Swedish (sv)
Other versions
SE7706526L (sv
Inventor
R C Effland
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of SE7706526L publication Critical patent/SE7706526L/xx
Publication of SE425391B publication Critical patent/SE425391B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SE7706526A 1976-06-03 1977-06-03 Forfarande for framstellning av 3-(3-karboxi-4-hydroxifenyl)-4,5-dihydro-2-fenylbens /e/ indol med verdefulla terapeutiska egenskaper SE425391B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/692,331 US4066659A (en) 1976-06-03 1976-06-03 Method of preparation of 3-(3-carboxy-4-hydroxyphenyl)-4,5-dihydro-2-phenylbenz (e) indole and valuable intermediates related thereto

Publications (2)

Publication Number Publication Date
SE7706526L SE7706526L (sv) 1977-12-04
SE425391B true SE425391B (sv) 1982-09-27

Family

ID=24780138

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7706526A SE425391B (sv) 1976-06-03 1977-06-03 Forfarande for framstellning av 3-(3-karboxi-4-hydroxifenyl)-4,5-dihydro-2-fenylbens /e/ indol med verdefulla terapeutiska egenskaper

Country Status (14)

Country Link
US (1) US4066659A (xx)
JP (1) JPS5325556A (xx)
AT (1) AT353786B (xx)
BE (1) BE855406A (xx)
CA (1) CA1105936A (xx)
CH (1) CH629774A5 (xx)
DE (1) DE2724601A1 (xx)
DK (1) DK145296C (xx)
ES (1) ES459256A1 (xx)
FI (1) FI65059C (xx)
HU (1) HU176801B (xx)
IT (1) IT1076781B (xx)
NL (1) NL7705807A (xx)
SE (1) SE425391B (xx)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1356431A (en) * 1971-06-03 1974-06-12 Wyeth John & Brother Ltd Substituted benz-g-indoles
US3931407A (en) * 1973-03-01 1976-01-06 American Hoechst Corporation Method of treatment with and compositions containing condensed pyrroles bearing an N-phenyl substituent

Also Published As

Publication number Publication date
DK145296C (da) 1983-03-14
ATA392877A (de) 1979-05-15
HU176801B (en) 1981-05-28
BE855406A (fr) 1977-12-05
FI771747A (xx) 1977-12-04
CH629774A5 (de) 1982-05-14
CA1105936A (en) 1981-07-28
SE7706526L (sv) 1977-12-04
AT353786B (de) 1979-12-10
NL7705807A (nl) 1977-12-06
DK145296B (da) 1982-10-25
DE2724601A1 (de) 1977-12-22
FI65059B (fi) 1983-11-30
JPS5325556A (en) 1978-03-09
US4066659A (en) 1978-01-03
IT1076781B (it) 1985-04-27
ES459256A1 (es) 1978-03-01
DK243677A (da) 1977-12-04
FI65059C (fi) 1984-03-12
DE2724601C2 (xx) 1988-03-03
JPS6120546B2 (xx) 1986-05-22

Similar Documents

Publication Publication Date Title
SE435059B (sv) Forfarande for framstellning av med kveveheterocykliska grupper substituerade 1-fenyl-2-alkylaminoetanol-foreningar
NO152899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glycerolderivater.
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
NO155885C (no) Analogifremgangsmaate for fremstilling av tiazolderivater med anti-ulcus-egenskaper.
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
NO782043L (no) Fremgangsmaate ved fremstilling av 3-(a-pyrazolyl)-pyridazinderivater.
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
NO151365C (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater.
SE7604475L (sv) Forfarande for framstellning av 1,1,1-triaryl-alkylaminer
SE429338B (sv) Forfarande for framstellning av substituerade 2-bensylpyrrolidiner med terapeutisk verkan
NO156086C (no) Analogifremgangsmaate for fremstilling av substituerte heterocykliske fenoksyaminer.
SE423813B (sv) Forfarande for framstellning av 1,5-disubstituerade pyrrolidoner med terapeutiska egenskaper
SE419983B (sv) Forfarande for framstellning av finkornig, fast cyanurklorid
NO801171L (no) Fremgangsmaate for fremstilling av fenylglycylklorid-hydroklorid-derivater.
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
SE428922B (sv) Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner
SE7505439L (sv) Forfarande for framstellning av 3-(5-nitroimidazol-2-yl)-pyrazolo 3,4-d -pyrimidinforeningar.
SE425391B (sv) Forfarande for framstellning av 3-(3-karboxi-4-hydroxifenyl)-4,5-dihydro-2-fenylbens /e/ indol med verdefulla terapeutiska egenskaper
SE7600847L (sv) Nytt forfarande for framstellning av 8-bromtienotriazolo-1,4-diazepiner
NO154131C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
AR220228A1 (es) Procedimiento para la preparacion de derivados de tiazin-1,3-(3,4-b)-isoquinoleina
NO154635C (no) Fremgangsmaate for fremstilling av terapeutisk aktive ergotalkaloider.
SE7608453L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
NO144067C (no) Fremgangsmaate for fremstilling av di-n-propylacetonitril.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7706526-6

Effective date: 19910131

Format of ref document f/p: F